Author:
Kim Jeong Yeon,Kim Nam Kyu,Sohn Seung Kook,Kim Yong Wan,Kim Kim Jin Soo,Hur Hyuk,Min Byung Soh,Cho Chang Hwan
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Hutter RV. At last–worldwide agreement on the staging of cancer. Arch Surg. 1987;122:1235–9.
2. Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg. 2002;236:416–21.
3. Merkel S, Mansmann U, Papadopoulos T, et al. The prognostic inhomogeneity of colorectal carcinomas Stage III: a proposal for subdivision of Stage III. Cancer. 2001;92:2754–9.
4. Ahnen DJ, Feigl P, Quan G, et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res. 1998;58:1149–58.
5. Andreyev HJ, Norman AR, Cunningham D, et al. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study. Br J Cancer. 2001;85:692–6.